Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed -$4 556
2025
Q3
$4 Sell
1
-1
-50% -$5 ﹤0.01% 549
2025
Q2
$9 Sell
2
-3
-60% -$10 ﹤0.01% 532
2025
Q1
$8 Hold
5
﹤0.01% 508
2024
Q4
$14 Hold
5
﹤0.01% 498
2024
Q3
$27 Hold
5
﹤0.01% 497
2024
Q2
$84 Hold
5
﹤0.01% 931
2024
Q1
$58 Hold
5
﹤0.01% 921
2023
Q4
$83 Hold
5
﹤0.01% 464
2023
Q3
$113 Hold
5
﹤0.01% 907
2023
Q2
$0 Hold
5
﹤0.01% 887
2023
Q1
$0 Buy
+5
New +$211 ﹤0.01% 908
2022
Q2
Sell
-5
Closed 918
2022
Q1
$0 Hold
5
﹤0.01% 926
2021
Q4
$0 Hold
5
﹤0.01% 938
2021
Q3
$1K Hold
5
﹤0.01% 896
2021
Q2
$1K Buy
+5
New +$375 ﹤0.01% 901
2021
Q1
Sell
-5
Closed 951
2020
Q4
$0 Hold
5
﹤0.01% 909
2020
Q3
$0 Hold
5
﹤0.01% 907
2020
Q2
$0 Hold
5
﹤0.01% 982
2020
Q1
$0 Hold
5
﹤0.01% 966
2019
Q4
$0 Hold
5
﹤0.01% 909
2019
Q3
$0 Hold
5
﹤0.01% 923
2019
Q2
$0 Hold
5
﹤0.01% 1028
2019
Q1
$0 Buy
+5
New +$310 ﹤0.01% 1059

Other funds holding AGEN

Front Row Advisors's AGEN Position: Q4 2025 in Review

Front Row Advisors sold out of Agenus (AGEN) in Q4 2025, closing a stake of 1 share — an estimated $4 sold.

Front Row Advisors first reported a position in AGEN in Q1 2019 and held it in 23 quarters. The position peaked at $1K in Q3 2021. 96 funds tracked by Wall St. Rank hold AGEN as of Q4 2025.

  • Front Row Advisors reported no remaining Agenus position as of Q4 2025 after selling out during the quarter.
  • Front Row Advisors sold 1 Agenus share in Q4 2025, an estimated $4.
  • Front Row Advisors first reported a position in Agenus in Q1 2019 and held it in 23 quarters.
  • Front Row Advisors's Agenus position peaked at $1K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Agenus as of Q4 2025.

Based on Front Row Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.